TScan Therapeutics Inc

Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.

Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.

Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.

In its most recent quarterly, TScan Therapeutics Inc had 128.06M in cash and cash equivalents.

TScan Therapeutics Inc reported 105.67M in total liabilities as of the latest reported quarter, including 18.70M in current liabilities and 86.97M in non-current liabilities.

As of the latest reported quarter, TScan Therapeutics Inc's total assets were 228.79M, consisting of 157.21M in current assets and 71.58M in non-current assets.

TScan Therapeutics Inc reported 123.12M in total shareholders' equity as of the latest reported quarter.